CompaniesEximias Pharmaceutical

Eximias Pharmaceutical

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

By Phase

PHASE3: 1

By Status

COMPLETED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
1999
2000
2001
2002
2003
2004
2005
2006
Today
NCT00012324
Hover over trial bars to see details

Recent Trials

NCT00012324Lead Sponsor
Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer
PHASE3Completed
Started: Sep 30, 2000 · Completed: Nov 30, 2005
Related Companies
Ym Biosciences
acquired